Valuation: Prenetics Global Limited

Market Cap 342M 304M 283M 258M 487M 32.84B 492M 3.43B 1.33B 16.79B 1.28B 1.25B 53.88B P/E 2026 *
-5.83x
P/E 2027 * -14.3x
Enterprise Value 342M 304M 283M 258M 487M 32.84B 492M 3.43B 1.33B 16.79B 1.28B 1.25B 53.88B EV / Sales 2026 *
1.53x
EV / Sales 2027 * 0.85x
Free-Float
85.46%
Yield 2026 *
-
Yield 2027 * -
1 day-8.11%
1 week-12.19%
Current month-12.80%
1 month-20.72%
3 months+19.14%
6 months+2.49%
Current year+28.06%
1 week 19.85
Extreme 19.85
23.6
1 month 19.85
Extreme 19.85
26.4
Current year 14
Extreme 14
27.24
1 year 11.36
Extreme 11.365
27.24
3 years 2.85
Extreme 2.85
27.24
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 52 01/01/2014
Chief Executive Officer 47 01/01/2014
Director of Finance/CFO 41 01/01/2018
Director TitleAgeSince
Chairman 47 01/01/2014
Director/Board Member 38 -
Director/Board Member - 16/02/2026
Date Insider Type Main position Quantity % Market Cap. Importance
4/9/26 Exercice

Director

4,000 0.0257%
25/8/26 Buy

CFO of IM8 (US) LLC

5,100 0.0328%
24/8/26 Buy

Chief Executive Officer

17,181 0.1104%
Change 5-day change 1-year change 3-year change Capi.($)
-8.11%-12.19%+41.35%+204.71% 342M
+0.84%-3.74%-27.56%+1.93% 169B
-0.07%-2.55%-11.59%+13.26% 110B
+0.90%+1.13%-25.66%+3.47% 106B
-1.24%-0.76%-49.50%-12.46% 73.87B
-0.24%+0.69%+2.08%+69.19% 58.98B
+1.99%+4.49%+9.24%+62.87% 51.28B
-0.71%-3.82%-8.68%-31.93% 48.16B
+0.12%-0.17%-17.87%+19.66% 40.84B
-1.01%-1.45%+27.31%-2.67% 32.21B
Average -0.76%-1.99%-6.09%+32.80% 69.05B
Weighted average by Cap. +0.23%-1.30%-17.31%+11.28%

Financials

2026 *2027 *
Net sales 224M 199M 186M 169M 319M 21.53B 322M 2.25B 871M 11.01B 841M 823M 35.32B 404M 359M 335M 305M 575M 38.8B 581M 4.05B 1.57B 19.84B 1.52B 1.48B 63.66B
Net income -61.71M -54.83M -51.18M -46.65M -87.98M -5.93B -88.79M -619M -240M -3.03B -232M -227M -9.73B -24.22M -21.52M -20.08M -18.3M -34.52M -2.33B -34.84M -243M -94.17M -1.19B -90.92M -88.95M -3.82B
Net Debt - -
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
98
Date Price Change Volume
02/10/26 USD 20.17 -8.11% 311,526
01/10/26 USD 21.95 -5.10% 94,421
30/09/26 USD 23.13 +1.27% 67,312
29/09/26 USD 22.84 +0.35% 65,892
28/09/26 USD 22.76 -0.91% 74,348
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
20.17USD
Average target price
35.86USD
Spread / Average Target
+77.77%

Quarterly revenue - Rate of surprise